Back to Market Feed

JOURNAVX 50 MG TABLET

Suzetrigine
$14.8415per EA

Strength

50 mg/1

NDC

51167054830

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

SUZETRIGINE

Approval Type

New Drug (NDA)

FDA Application

NDA219209

On Market Since

1/30/2025

Pharmacological Classes

Cytochrome P450 3A Inducers
Sodium Channel Antagonists
Sodium Channel Blocker

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

-0.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.1%

Generic Alternatives

1 alternative • Same active ingredient

JOURNAVX 50 MG TABLET
Brand
51167054834•Vertex Pharmaceuticals Incorporated
$14.8415

Related Drugs

Same classification

KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
KALETRA 200-50 MG TABLET
Brand
00074401412•AbbVie Inc.
$8.3041
per EA
KALETRA 200-50 MG TABLET
Brand
00074679922•AbbVie Inc.
$8.3041
per EA
NORVIR 100 MG TABLET
Brand
00074234030•AbbVie Inc.
$8.3462
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
ORILISSA 200 MG TABLET
Brand
00074003956•AbbVie Inc.
$21.9134
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.2861
per EA
XCOPRI 25 MG TABLET
Brand
71699002530•SK Life Science, Inc.
$39.8682
per EA
XCOPRI 50 MG TABLET
Brand
71699005030•SK Life Science, Inc.
$39.8997
per EA
XCOPRI 100 MG TABLET
Brand
71699010030•SK Life Science, Inc.
$39.9308
per EA